Cboe’s 29 September extension of its S&P Dow Jones Indices agreement secures exclusive SPX options rights through 2051. It gives the exchange and its trading partners a long horizon for the core product relationship. A separate financial disclosure sets out the cost change: existing royalty terms continue for 2026, with updated terms beginning in 2027.[1][2]
The 2027 reset establishes a new cost base
The agreement also allows collaboration on further innovations, potentially including tokenised options. That remains a product-development possibility, without a contract specification, approval or launch commitment in the announcement.[1]
The disclosed economic timetable
| Period | Published position | Commercial implication |
|---|---|---|
| 2026 | Royalty terms unchanged | Existing terms continue for this yearSource 2 |
| 2027 | Updated royalty terms begin | Volume, pricing and execution determine the net effectSource 2 |
| Later adjustments | Expected to be smaller than the 2027 reset | No complete royalty-rate schedule disclosedSource 2 |
Cboe expects a very small effect on 2027 net revenue growth after considering organic and ecosystem-driven volume growth, pricing opportunities and business execution. That is a forecast for the combined business outcome: the gross royalty increase can still be meaningful. More specific guidance was planned with fourth-quarter earnings in February.[2]
Volume and product mix shape the offset
Cboe’s 12 October review reported third-quarter SPX average daily volume of 4.9 million contracts, including 3.2 million zero-days-to-expiry contracts. Those rounded figures put zero-day activity at roughly 65% of the quarterly total. September’s separate zero-day figure was 3.4 million a day; it should not replace the quarterly numerator in that calculation.[3]
Scale makes small unit-cost changes significant. As a sensitivity example, an assumed additional cost of one US cent per contract applied to 4.9 million daily contracts would equal $49,000 per trading day. This is arithmetic using the reported volume, not the disclosed royalty rate or an earnings forecast. Actual charges, qualifying volumes, product mix and realised revenue per contract would determine the financial effect.[3]
Product continuity supports investment in trading infrastructure
SPX options use cash settlement, European-style exercise and a $100 multiplier. Broker routing, account permissions, expiry handling and risk calculations must match those mechanics. The contract provides index exposure rather than ownership of the underlying shares.[4]
A long licensing horizon can reduce uncertainty for intermediaries investing in connectivity and risk systems around that product. Liquidity at individual strikes, exchange fee decisions and broker charges remain separate commercial variables.
The next earnings guidance can help distinguish a durable volume-and-pricing offset from one dependent on unusually strong activity. Useful evidence will connect contract volumes and revenue per contract with the revised royalty burden. That bridge would explain how the secured product franchise translates into net revenue growth.
Sources & further reading
- Cboe and S&P Dow Jones Indices sign 25-year licensing extension through 2051 Cboe / S&P Dow Jones Indices · 29 Sep 2026 · Accessed 20 Oct 2026
- Additional details on anticipated financial impacts of the S&P DJI licensing extension Cboe · 29 Sep 2026 · Accessed 20 Oct 2026
- Market metrics that matter: derivatives September 2026 volume highlights Cboe · 12 Oct 2026 · Accessed 20 Oct 2026
- S&P 500 Index options: SPX Cboe · Accessed 20 Oct 2026